(Q82915838)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16554289%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

Effect of omeprazole on bioavailability of an oral extended-release formulation of ciprofloxacin (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16554289%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference

1 reference

Carla Washington

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16554289%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Eddie Hou

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16554289%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Nicki Hughes

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16554289%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Bret Berner

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16554289%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

1 April 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16554289%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Health-System Pharmacy

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16554289%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

63

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16554289%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16554289%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

653-656

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16554289%20AND%20SRC:MED&resulttype=core&format=json

Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050355

Clinical pharmacokinetics of ciprofloxacin

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050355

Ciprofloxacin absorption in different regions of the human gastrointestinal tract. Investigations with the hf-capsule

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050355

Omeprazole drug interaction studies

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050355

Omeprazole: pharmacology, pharmacokinetics and interactions

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050355

Interaction study of lomefloxacin and ciprofloxacin with omeprazole and comparative pharmacokinetics

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050355

Efficacy and safety of a novel once-daily extended-release ciprofloxacin tablet formulation for treatment of uncomplicated urinary tract infection in women

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050355

Pharmacokinetics and pharmacodynamics of a novel extended-release ciprofloxacin in healthy volunteers

31 March 2020

1 reference

https://api.crossref.org/works/10.2146%2FAJHP050355

31 March 2020

Identifiers

DOI

10.2146/AJHP050355

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16554289%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference